Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-03

Clinical Trial Update: PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pentoxifylline plus tocopherol (vitamin E) for post-radiotherapy fibrosis in head and neck cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pentoxifylline (pentoxifylline)
  • Tocopherol (Vitamin E)

Snippet

Sponsor: University College, London | Conditions: Head and Neck Fibrosis | Phase 1 | Status: COMPLETED